Existing risk assessment strategies for predicting mortality in PAH may be improved by the addition of GDF-15 as a biomarker.

Influenza prevention with the cell-based quadrivalent vaccine (QIVc) was superior to the egg-based vaccine (QIVe) during the US 2022–2023 flu season.

Medicaid expansion was associated with a significant reduction in mortality in patients with resectable NSCLC.

Long-term exposure to black carbon is associated with an increased risk for developing asthma and chronic obstructive pulmonary disease.

The United States again earned a D+ grade for preterm birth, according to the 2025 March of Dimes Report Card.

Nirmatrelvir-ritonavir use was associated with substantially lower rates of COVID-19-related hospitalization among high-risk outpatients.

Risk factors for rheumatoid arthritis-related lung diseases include later RA onset, longer RA duration, and previous pulmonary infections.

Tezepelumab reduced exacerbations across all seasons in severe uncontrolled asthma, even among patients with perennial and seasonal allergies.

Cannabis use is associated with a lower risk for alcohol-associated liver disease in patients with alcohol use disorder.

For those with ALK+ NSCLC who received first-line, next-generation ALK TKI monotherapy, continuing ALK TKI with chemotherapy is linked to better outcomes.

The GOLD COPD Update 2026 provides updated guidance on case-finding, disease activity, exacerbation management.

Diabetes care can greatly benefit from the implementation of telemedicine, but older adults still face accessibility barriers ...